Clinical Trial Update: Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating marizomib with bevacizumab, then marizomib alone, then marizomib with bevacizumab in malignant glioma/glioblastoma; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Marizomib (marizomib)

Snippet

Sponsor: Celgene | Conditions: Malignant Glioma, Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-08